Bio-Rad Laboratories, Inc.
Updates & Highlights
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Bio-Rad Laboratories, Inc.?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentBio-Rad Laboratories, Inc. (BIO.B.US) will release its earnings report after market close on August 5.
Bio-Rad Laboratories, Inc. (BIO.B.US) will release its earnings report after market close on August 5.
富途牛牛 · 3 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts
Yahoo Finance · 4 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts
Yahoo Finance · 11 days ago
ETFs Investing in Bio-Rad Laboratories, Inc. Class A Stocks
ETFs Investing in Bio-Rad Laboratories, Inc. Class A Stocks
TradingView · 16 days ago
Price to earnings forward of Bio-Rad Laboratories, Inc. – NYSE:BIO
Price to earnings forward of Bio-Rad Laboratories, Inc. – NYSE:BIO
TradingView · 20 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating Growth Amidst Stable Price Movements
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating Growth Amidst Stable Price Movements
DirectorsTalk Interviews · about 1 month ago
Bio-Rad Laboratories, Inc. Class B Actuals & Estimates (LSX:862449)
Bio-Rad Laboratories, Inc. Class B Actuals & Estimates (LSX:862449)
TradingView · about 1 month ago
Bio-Rad Laboratories, Inc. Class B Actuals & Estimates (FWB:BUW)
Bio-Rad Laboratories, Inc. Class B Actuals & Estimates (FWB:BUW)
TradingView · about 1 month ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential
DirectorsTalk Interviews · 2 months ago
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
富途牛牛 · 2 months ago
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
Moomoo · 2 months ago
BIO-RAD LABORATORIES, INC. SEC Filing (May 28, 2026)
BIO-RAD LABORATORIES, INC. SEC Filing (May 28, 2026)
Stock Titan · 2 months ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside
DirectorsTalk Interviews · 2 months ago
Bio-Rad Laboratories, Inc. Class B Trade Ideas — BOATS:BIO.B
Bio-Rad Laboratories, Inc. Class B Trade Ideas — BOATS:BIO.B
TradingView · 2 months ago
Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449
Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449
TradingView · 3 months ago
Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO
Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO
TradingView · 3 months ago
Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449
Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449
TradingView · 3 months ago
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO
FinancialContent · 3 months ago
Bio-Rad Laboratories, Inc. Q1 2026 earnings preview
Bio-Rad Laboratories, Inc. Q1 2026 earnings preview
MSN · 3 months ago
Bio-Rad Laboratories, Inc. (BIO) Investor Outlook: Navigating The 11.58% Potential Upside
Bio-Rad Laboratories, Inc. (BIO) Investor Outlook: Navigating The 11.58% Potential Upside
DirectorsTalk Interviews · 3 months ago